Hope Charities Backs New Bill to Empower Patients in Specialty Care Choices
Hope Charities has come forth with strong support for H.R. 10549, known as the Patients Choice in Specialty Pharmacy Act, which seeks to return control and choice to patients dealing with complex and rare medical conditions. Introduced on September 24, 2026, by Representative Neal Dunn from Florida and co-sponsored by Representative Joe Wilson of South Carolina, this pivotal legislation has now been referred to the House Committee on Energy and Commerce, demanding urgent action from Congress.
The primary focus of H.R. 10549 is to grant patients the freedom to choose any accredited specialty pharmacy that accepts the health plan's terms and rates, potentially ending the current trend where insurers and pharmacy benefit managers (PBMs) steer patients only towards their own affiliated pharmacies. This practice not only limits patient options but can delay access to life-saving medications and necessary healthcare, which can have dire consequences for those reliant on timely care.
Jonathan James, President and CEO of Hope Charities, highlighted the crucial need for change. He noted that many patients with chronic conditions already face significant burdens, including high costs and extensive time spent on treatment and specialist consultations. Delays caused by pharmacy directs, miscommunications, or restrictive prior authorizations can adversely affect patient outcomes, leading to preventable hospitalizations and increased overall healthcare costs.
"When a specialty medication or its administration is misunderstood, delayed by delivery errors, or stuck in prior authorization, patients often have nowhere else to turn," he emphasized. He believes that fostering competition among specialty pharmacies would significantly enhance patient care, allowing individuals to select pharmacies that understand their specific conditions and provide essential support services, including in-home care.
The bill proposes several fundamental changes to how specialty pharmacies operate within health insurance plans:
1. Non-Discrimination in Choices: Patients will not be compelled to use plan or PBM-affiliated pharmacies, which could involve penalties such as higher copays or deductibles elsewhere. This ensures patients can choose a pharmacy without fear of financial repercussions.
2. Equal Access: Licensed specialty pharmacies that comply with plan rules and reimbursement terms must not be excluded from networks, enabling a broader array of options for patients.
3. Quality Control: While the bill mandates that plans can require certain accreditation levels for pharmacies, it also allows exclusion based on history of fraud or patient harm, maintaining a quality standard in care delivery.
Importantly, H.R. 10549 does not force any patients to change their existing pharmacies, particularly if they are satisfied with their current arrangements, including those owned by plans. It does not impose price controls or initiate any breakup of existing pharmacy operations. The legislation is designed to take effect for plan years beginning January 1, 2029, providing ample time for adjustments.
This initiative draws inspiration from existing Medicare regulations, where Part D plans have long embraced the principle of allowing any pharmacy that meets uniform terms to compete for patients. This concept, reinforced by the recent Consolidated Appropriations Act, 2026, aims to replicate that success in commercial insurance.
As Jonathan James aptly stated, "If a plan-owned pharmacy offers the best care, patients will choose it. This bill allows every qualified pharmacy to compete on service and quality, on equal terms." He advocates that patient rights should transcend political lines, emphasizing a collective responsibility to prioritize patients over corporate interests.
Hope Charities is actively calling upon Members of Congress to cosponsor H.R. 10549, urging a robust response to ensure that patients regain their rightful autonomy in healthcare decisions. For additional information, you can visit Hope Charities for resources and ways to advocate.
With H.R. 10549, patients who struggle with severe health conditions may soon find themselves empowered to make more informed and personalized choices about their specialty pharmacy needs, leading to improved health outcomes and a better quality of life.
For those interested in cosponsoring the bill or sharing their personal experiences and advocacy efforts, visit Hope Charities' official channels for additional support and connections.
Hope Charities, Inc. is a nationally recognized nonprofit organization headquartered in Prairieville, Louisiana, dedicated to improving access to care for individuals with rare and complex conditions since 2009.
The primary focus of H.R. 10549 is to grant patients the freedom to choose any accredited specialty pharmacy that accepts the health plan's terms and rates, potentially ending the current trend where insurers and pharmacy benefit managers (PBMs) steer patients only towards their own affiliated pharmacies. This practice not only limits patient options but can delay access to life-saving medications and necessary healthcare, which can have dire consequences for those reliant on timely care.
Jonathan James, President and CEO of Hope Charities, highlighted the crucial need for change. He noted that many patients with chronic conditions already face significant burdens, including high costs and extensive time spent on treatment and specialist consultations. Delays caused by pharmacy directs, miscommunications, or restrictive prior authorizations can adversely affect patient outcomes, leading to preventable hospitalizations and increased overall healthcare costs.
"When a specialty medication or its administration is misunderstood, delayed by delivery errors, or stuck in prior authorization, patients often have nowhere else to turn," he emphasized. He believes that fostering competition among specialty pharmacies would significantly enhance patient care, allowing individuals to select pharmacies that understand their specific conditions and provide essential support services, including in-home care.
Key Provisions of H.R. 10549
The bill proposes several fundamental changes to how specialty pharmacies operate within health insurance plans:
1. Non-Discrimination in Choices: Patients will not be compelled to use plan or PBM-affiliated pharmacies, which could involve penalties such as higher copays or deductibles elsewhere. This ensures patients can choose a pharmacy without fear of financial repercussions.
2. Equal Access: Licensed specialty pharmacies that comply with plan rules and reimbursement terms must not be excluded from networks, enabling a broader array of options for patients.
3. Quality Control: While the bill mandates that plans can require certain accreditation levels for pharmacies, it also allows exclusion based on history of fraud or patient harm, maintaining a quality standard in care delivery.
What H.R. 10549 Does Not Propose
Importantly, H.R. 10549 does not force any patients to change their existing pharmacies, particularly if they are satisfied with their current arrangements, including those owned by plans. It does not impose price controls or initiate any breakup of existing pharmacy operations. The legislation is designed to take effect for plan years beginning January 1, 2029, providing ample time for adjustments.
A Proven Standard for Patient Freedom
This initiative draws inspiration from existing Medicare regulations, where Part D plans have long embraced the principle of allowing any pharmacy that meets uniform terms to compete for patients. This concept, reinforced by the recent Consolidated Appropriations Act, 2026, aims to replicate that success in commercial insurance.
As Jonathan James aptly stated, "If a plan-owned pharmacy offers the best care, patients will choose it. This bill allows every qualified pharmacy to compete on service and quality, on equal terms." He advocates that patient rights should transcend political lines, emphasizing a collective responsibility to prioritize patients over corporate interests.
Hope Charities is actively calling upon Members of Congress to cosponsor H.R. 10549, urging a robust response to ensure that patients regain their rightful autonomy in healthcare decisions. For additional information, you can visit Hope Charities for resources and ways to advocate.
With H.R. 10549, patients who struggle with severe health conditions may soon find themselves empowered to make more informed and personalized choices about their specialty pharmacy needs, leading to improved health outcomes and a better quality of life.
Contact Details
For those interested in cosponsoring the bill or sharing their personal experiences and advocacy efforts, visit Hope Charities' official channels for additional support and connections.
Hope Charities, Inc. is a nationally recognized nonprofit organization headquartered in Prairieville, Louisiana, dedicated to improving access to care for individuals with rare and complex conditions since 2009.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.